VC
CRI icon

VarCov Co’s Carter's CRI Stock Holding History

VarCov Co’s Portfolio CRI Stock Details CRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,455
Closed -$274K – 424
2025
Q4 		$274K Buy
+8,455
New +$264K 0.11% 309

Other funds holding CRI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RWWM Inc Rocklin, California $1.35B AUM 9.17% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

VarCov Co's CRI Position: Q1 2026 in Review

VarCov Co sold out of Carter's (CRI) in Q1 2026, closing a stake of 8,455 shares — an estimated $274K sold.

VarCov Co first reported a position in CRI in Q4 2025 and held it in 1 quarter. The position peaked at $274K in Q4 2025. 275 funds tracked by Wall St. Rank hold CRI as of Q1 2026.

  • VarCov Co reported no remaining Carter's position as of Q1 2026 after selling out during the quarter.
  • VarCov Co sold 8,455 Carter's shares in Q1 2026, an estimated $274K.
  • VarCov Co first reported a position in Carter's in Q4 2025 and held it in 1 quarter.
  • VarCov Co's Carter's position peaked at $274K in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Carter's as of Q1 2026.

Based on VarCov Co's 13F filing for Q1 2026, filed 15 May 2026.